These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7249568)

  • 1. [Calcium-2,2'-disulfohexanoate in the treatment of liver diseases: study of a series of 15 patients].
    Piludu G; Perpignano G
    Clin Ter; 1981 May; 97(4):377-82. PubMed ID: 7249568
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute and chronic liver diseases with calcium-2,2'-disulfohexanoate].
    Ravetta A
    Clin Ter; 1979 Aug; 90(4):357-68. PubMed ID: 262631
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in some blood chemical parameters in patients with chronic liver diseases treated with calcium-2,2'-disulfohexanoate].
    Turpini R; Scotti A; Brusoni V; Perego M
    Clin Ter; 1980 Jun; 93(6):689-94. PubMed ID: 7428323
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of the activity of calcium-2,2'-disulfohexanoate in liver insufficiency].
    Romboli L; Leonardi R; Bertucci P; Fortunati P
    Clin Ter; 1978 Nov; 87(3):265-72. PubMed ID: 753574
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of calcium 2,2'-disulfohexanoate in chronic hepatopathies].
    Ortolan A; Martin A; Pieropan G
    Minerva Dietol Gastroenterol; 1978; 24(1):7-11. PubMed ID: 740272
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of calcium 2,2'-disulfohexanoate on the course of acute viral hepatitis: double-blind study].
    Calonghi G; Sueri L
    Clin Ter; 1982 Nov; 103(3):273-82. PubMed ID: 6759010
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatotropic action of calcium 2,2'-disulfohexanoate].
    Ferrari B; Della Seta L; Boscaini M; Piccini Leopardi M
    Clin Ter; 1978 Apr; 85(2):163-72. PubMed ID: 657746
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effects of calcium-2,2'-disulfohexanoate in hepatic cirrhosis].
    Cangiano C; Angelico M; Rossi Fanelli F
    Clin Ter; 1978 Aug; 86(4):337-53. PubMed ID: 737963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of therapeutic activity of a new pharmacologic combination in patients with chronic liver and debilitating diseases].
    Pasotti C; Buniva G; Carpinella G
    Clin Ter; 1971 Mar; 56(5):427-39. PubMed ID: 5564990
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of the short-term treatment of active chronic liver diseases with betamethasone].
    Sarti F; Milandri GL; Giuliani Piccari G; Formica G; Spongano P; Accardo P
    G Clin Med; 1982 Jun; 63(6):392-400. PubMed ID: 6816654
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic study of hexanoic acid in tympanoplasties].
    Charachon R; Junien-Lavillauroy PC; Serero C; Accoyer B
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 May; 24(5):401-2. PubMed ID: 126284
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical demonstration of the action of liver drugs].
    Einsiedel-Schömer W
    Z Allgemeinmed; 1973 Oct; 49(30):1452-5. PubMed ID: 4588532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcium-2, 2'-disulfo-hexanoate in the treatment of chronic hepatitis].
    Ninno ED; Tronaghi G; Idèo
    Clin Ter; 1975 Nov; 75(3):257-71. PubMed ID: 776508
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative examinations by internists before reoperation].
    Kettner W; Mokros W
    Zentralbl Chir; 1984; 109(5):297-308. PubMed ID: 6720124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of 37 cases of jaw fractures treated with N-acetyl-amino-6-hexanoic acid].
    Garlin J
    Rev Odontostomatol Midi Fr; 1971; 29(2):143-7. PubMed ID: 5131319
    [No Abstract]   [Full Text] [Related]  

  • 17. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
    Lindblad A; Glaumann H; Strandvik B
    Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver enzyme testing.
    Colyar MR
    Adv Nurse Pract; 2001 Mar; 9(3):31. PubMed ID: 12400321
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of abnormal liver tests.
    Fregia A; Jensen DM
    Compr Ther; 1994; 20(1):50-4. PubMed ID: 8137620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory diagnosis of chronic liver diseases].
    TEICHMANN W
    Z Arztl Fortbild (Jena); 1963 Apr; 57():387-90. PubMed ID: 13980453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.